Early dysfunction and progressive degeneration of the subthalamic nucleus in mouse models of Huntington's disease

  1. Jeremy F Atherton
  2. Eileen L McIver
  3. Matthew RM Mullen
  4. David L Wokosin
  5. D James Surmeier
  6. Mark D Bevan  Is a corresponding author
  1. Feinberg School of Medicine, Northwestern University, United States

Abstract

The subthalamic nucleus (STN) is an element of cortico-basal ganglia-thalamo-cortical circuitry critical for action suppression. In Huntington's disease (HD) action suppression is impaired, resembling the effects of STN lesioning or inactivation. To explore this potential linkage, the STN was studied in BAC transgenic and Q175 knock-in mouse models of HD. At < 2 and 6 months of age autonomous STN activity was impaired due to activation of KATP channels. STN neurons exhibited prolonged NMDA receptor-mediated synaptic currents, caused by a deficit in glutamate uptake, and elevated mitochondrial oxidant stress, which was ameliorated by NMDA receptor antagonism. STN activity was rescued by NMDA receptor antagonism or breakdown of hydrogen peroxide. At 12 months of age approximately 30% of STN neurons were lost, as in HD. Together these data argue that dysfunction within the STN is an early feature of HD that may contribute to its expression and course.

Article and author information

Author details

  1. Jeremy F Atherton

    Department of Physiology, Feinberg School of Medicine, Northwestern University, Chicago, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Eileen L McIver

    Department of Physiology, Feinberg School of Medicine, Northwestern University, Chicago, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Matthew RM Mullen

    Department of Physiology, Feinberg School of Medicine, Northwestern University, Chicago, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. David L Wokosin

    Department of Physiology, Feinberg School of Medicine, Northwestern University, Chicago, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. D James Surmeier

    Department of Physiology, Feinberg School of Medicine, Northwestern University, Chicago, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Mark D Bevan

    Department of Physiology, Feinberg School of Medicine, Northwestern University, Chicago, United States
    For correspondence
    m-bevan@northwestern.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9759-0163

Funding

CHDI Foundation

  • Jeremy F Atherton
  • Mark D Bevan

National Institutes of Health (2R37 NS041280 and 2P50 NS047085)

  • Eileen L McIver
  • David L Wokosin
  • D James Surmeier
  • Mark D Bevan

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: This study was performed in accordance with the policies of the Society for Neuroscience and the National Institutes of Health. All animals were handled according to approved Institutional Animal Care and Use Committee protocols (IS00001185) of Northwestern University. All procedures were performed under isoflurane or ketamine/xylazine anesthesia, and every effort was made to minimize suffering.

Reviewing Editor

  1. Harry T Orr, University of Minnesota, United States

Publication history

  1. Received: September 17, 2016
  2. Accepted: December 8, 2016
  3. Accepted Manuscript published: December 20, 2016 (version 1)
  4. Version of Record published: December 29, 2016 (version 2)

Copyright

© 2016, Atherton et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,811
    Page views
  • 379
    Downloads
  • 14
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Jeremy F Atherton
  2. Eileen L McIver
  3. Matthew RM Mullen
  4. David L Wokosin
  5. D James Surmeier
  6. Mark D Bevan
(2016)
Early dysfunction and progressive degeneration of the subthalamic nucleus in mouse models of Huntington's disease
eLife 5:e21616.
https://doi.org/10.7554/eLife.21616

Further reading

    1. Neuroscience
    2. Stem Cells and Regenerative Medicine
    Xin-Yao Sun et al.
    Research Article Updated

    Brain organoids have been used to recapitulate the processes of brain development and related diseases. However, the lack of vasculatures, which regulate neurogenesis and brain disorders, limits the utility of brain organoids. In this study, we induced vessel and brain organoids, respectively, and then fused two types of organoids together to obtain vascularized brain organoids. The fused brain organoids were engrafted with robust vascular network-like structures and exhibited increased number of neural progenitors, in line with the possibility that vessels regulate neural development. Fusion organoids also contained functional blood–brain barrier-like structures, as well as microglial cells, a specific population of immune cells in the brain. The incorporated microglia responded actively to immune stimuli to the fused brain organoids and showed ability of engulfing synapses. Thus, the fusion organoids established in this study allow modeling interactions between the neuronal and non-neuronal components in vitro, particularly the vasculature and microglia niche.

    1. Neuroscience
    2. Stem Cells and Regenerative Medicine
    Bilal Cakir, In-Hyun Park
    Insight

    Fusing brain organoids with blood vessel organoids leads to the incorporation of non-neural endothelial cells and microglia into the brain organoids.